Clinical Trials Directory

Trials / Conditions / Malignant Tumor

Malignant Tumor

49 registered clinical trials studyying Malignant Tumor12 currently recruiting.

StatusTrialSponsorPhase
RecruitingPsychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of L
NCT07193329
Gang Chen, MD
Not Yet RecruitingImpact of Family-Centered Empowerment on Caregivers of Children With Cancer: A Quasi-Experimental Study Protoc
NCT06810388
Xiaowan LiN/A
RecruitingEffectiveness of Central Oncology Navigation and the Use of an ORN
NCT06618274
UNC Lineberger Comprehensive Cancer CenterN/A
RecruitingRehabilitation Outcomes Study
NCT06674889
UNC Lineberger Comprehensive Cancer CenterN/A
Not Yet RecruitingApplication of LARS Ligament in Bone Prosthesis Replacement
NCT05616182
Henan Cancer Hospital
UnknownApplication of Douyin in Patients With Bone and Soft Tissue Malignant Tumors During Perichemotherapy
NCT05598827
Henan Cancer HospitalN/A
Not Yet RecruitingApplication of 3D Printed Prosthesis in Limb Salvage Surgery for Bone Tumors
NCT05616195
Henan Cancer Hospital
CompletedEffect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects
NCT06093945
Jiangsu HengRui Medicine Co., Ltd.Phase 1
UnknownThe Application of Novel Oncolytic Virus in Late Stage Solid Tumors
NCT06080984
West China HospitalPhase 1
Unknown99mTc-CNDG Injection in the Diagnosis of Malignant Tumors
NCT06030817
Peking Union Medical College HospitalN/A
RecruitingA Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies
NCT05862259
Xinqiao Hospital of Chongqing
UnknownIntervention, Prognosis and Mechanism of Covid-19 Infection in Patients With Underlying Diseases
NCT05965843
The Second Affiliated Hospital of Chongqing Medical University
RecruitingLong-term Follow-up of Anxiety and Depression in Patients With Malignant Tumors
NCT05596344
Henan Cancer Hospital
Unknown68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer
NCT06084767
Cancer Institute and Hospital, Chinese Academy of Medical SciencesN/A
RecruitingAlpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
NCT05781555
Alpha Tau Medical LTD.N/A
CompletedEffect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects
NCT05661591
Jiangsu HengRui Medicine Co., Ltd.Phase 1
Active Not RecruitingClinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
NCT05707910
West China HospitalPhase 1
CompletedPharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects
NCT05592262
Jiangsu HengRui Medicine Co., Ltd.Phase 1
RecruitingFirst-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid
NCT05495295
Phost'In TherapeuticsPhase 1
RecruitingClinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immu
NCT07400224
Peking Union Medical College HospitalPhase 1 / Phase 2
Active Not RecruitingPhase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in T
NCT05103358
Aadi Bioscience, Inc.Phase 2
CompletedA Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors
NCT04991506
Elpiscience Biopharma, Ltd.Phase 1
UnknownPirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP
NCT05280873
Zhou ChengzhiPhase 1
CompletedXCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)
NCT04926545
Guangzhou University of Traditional Chinese MedicineN/A
RecruitingA First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors
NCT04686682
Jacobio Pharmaceuticals Co., Ltd.Phase 1 / Phase 2
CompletedA Study of ES102 (OX40 Agonist) in Patients With Advanced Solid Tumors
NCT04730843
Elpiscience Biopharma, Ltd.Phase 1
CompletedStudy Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Com
NCT04952766
Centre Hospitalier Régional d'OrléansPhase 4
CompletedSurgical Approach for Retrorectal Tumors Cohort
NCT04757103
University Hospital, Montpellier
UnknownTreatment of Malignant Tumors With Antigen Peptide-specific DC-CTL Cells and Decitabine
NCT04672473
Shenzhen University General HospitalPhase 1 / Phase 2
UnknownCAR-T for r/r Malignant Tumors in Children
NCT04691349
PersonGen BioTherapeutics (Suzhou) Co., Ltd.EARLY_Phase 1
CompletedEstablishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis
NCT04793672
Zhejiang Cancer Hospital
UnknownDrugs for the Treatment of Multiple Sclerosis and Risk of Cancer: a Pharmacovigilance Analysis in Vigibase
NCT04237337
University Hospital, Caen
TerminatedA Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors
NCT04009460
Elpiscience Biopharma, Ltd.Phase 1
CompletedStimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea
NCT03354741
Centre Hospitalier Universitaire de NiceN/A
UnknownClinical Research of ROBO1 Specific BiCAR-NK/T Cells on Patients With Malignant Tumor
NCT03931720
Asclepius Technology Company Group (Suzhou) Co., Ltd.Phase 1 / Phase 2
UnknownProspective Screening Programme for Malignant Tumors
NCT04230200
Sun Yat-sen University
UnknownSerum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy
NCT03039062
Chinese Academy of Medical Sciences
UnknownEfficacy of Partial Covered Double Bare Metal Stent Compared to Uncovered Double Bare Metal Stent in Malignant
NCT02937246
Yonsei UniversityN/A
CompletedEffect of Intraoperative Dexmedetomidine on Development of Acute Kidney Injury
NCT02641938
Gangnam Severance HospitalPhase 4
CompletedAssessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a P
NCT02552004
IHU StrasbourgN/A
CompletedEvaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH
NCT02552381
Diagnostica Stago R&D
CompletedEpidural Anesthesia-analgesia and Long-term Outcome
NCT03012945
Peking University First HospitalN/A
TerminatedImaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381
Washington University School of MedicinePhase 1
CompletedGene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy
NCT01906632
Capital Medical UniversityN/A
CompletedStudy of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy
NCT01884168
Capital Medical University
UnknownA Multicenter "Ablate and Resect" Study of Novilase® Interstitial Laser Therapy for the Ablation of Small Brea
NCT01478438
Novian Health Inc.N/A
UnknownCancer Genome Analysis
NCT01458704
Seoul National University Hospital
UnknownSodium Selenite as a Cytotoxic Agent in Advanced Carcinoma
NCT01959438
Karolinska University HospitalPhase 1 / Phase 2
CompletedONO-7436 Phase II Study in Japan
NCT00212602
Ono Pharmaceutical Co., Ltd.Phase 2